For this new investigation, women with an elevated 5-year risk of breast cancer were asked to either continue with their usual care or continue with their usual care plus read a decision aid describing the risks and benefits of tamoxifen and raloxifene for breast cancer prevention. After reading the decision aid, the women completed a questionnaire about their perceptions and intentions related to these drugs. Actual behavior related to the use of these breast cancer prevention drugs was assessed 3 months later. The study investigators reported that:
- Only 8.1% of women who read the decision aid looked for additional information about breast cancer prevention.
- Only 1.8% of the women who read the decision aid talked to their doctor about raloxifene or tamoxifen for breast cancer prevention.
- Nearly 55% of of the women reading the decision aid chose not to take either drug.
- Less than 1% chose to take raloxifene and none chose to use tamoxifen.
- Overall, most of the women at high risk for breast cancer who read the decision aid did not believe that they would receive any benefit or reduction in breast cancer risk by taking either tamoxifen or raloxifene.
To learn about diet and lifestyle choices to reduce your breast cancer risk, read my FREE book FIGHT NOW: EAT & LIVE PROACTIVELY AGAINST BREAST CANCER. Please recommend to anyone interested in breast cancer, breast cancer treatment, and breast cancer symptoms.